Detalles de la búsqueda
1.
Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study.
Breast Cancer Res Treat
; 184(2): 421-431, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32770287
2.
Efficacy and safety of direct oral anticoagulants in the pediatric population: a systematic review and a meta-analysis.
J Thromb Haemost
; 21(10): 2784-2796, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37481075
3.
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors.
NPJ Breast Cancer
; 9(1): 27, 2023 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37069173
4.
Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitors.
Ther Adv Med Oncol
; 15: 17588359231204857, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38130467
5.
Role of the IGF-1 Axis in Overcoming Resistance in Breast Cancer.
Front Cell Dev Biol
; 9: 641449, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33829018
6.
Poly (ADP-ribose) polymerase inhibitors in solid tumours: Systematic review and meta-analysis.
Eur J Cancer
; 149: 134-152, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33862496
7.
Tumor Type Agnostic Therapy Carrying BRAF Mutation: Case Reports and Review of Literature.
Pharmaceuticals (Basel)
; 14(2)2021 Feb 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33669326
8.
Clinical, Radiometabolic and Immunologic Effects of Olaparib in Locally Advanced Triple Negative Breast Cancer: The OLTRE Window of Opportunity Trial.
Front Oncol
; 11: 686776, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34262869
9.
Canakinumab as treatment for COVID-19-related pneumonia: A prospective case-control study.
Int J Infect Dis
; 104: 433-440, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33385581
10.
Baseline Characteristics and Outcomes of Cancer Patients Infected with SARS-CoV-2 in the Lombardy Region, Italy (AIOM-L CORONA): A Multicenter, Observational, Ambispective, Cohort Study.
Cancers (Basel)
; 13(6)2021 Mar 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33809465
11.
Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor-Positive Advanced Breast Cancer (EVERMET).
Clin Cancer Res
; 27(12): 3443-3455, 2021 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33785482
12.
Impact of BMI on the outcome of metastatic breast cancer patients treated with everolimus: a retrospective exploratory analysis of the BALLET study.
Oncotarget
; 11(23): 2172-2181, 2020 Jun 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32577163
13.
Early Changes of the Standardized Uptake Values (SUVmax) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cancer.
Cancers (Basel)
; 12(11)2020 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33182575
14.
Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast Cancer.
Cells
; 8(4)2019 04 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30959874
15.
Addendum: Impact of BMI on the outcome of metastatic breast cancer patients treated with everolimus: a retrospective exploratory analysis of the BALLET study.
Oncotarget
; 13: 1307, 2022 Dec 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36473136
16.
Sirtuin 2 Inhibition Improves Cognitive Performance and Acts on Amyloid-ß Protein Precursor Processing in Two Alzheimer's Disease Mouse Models.
J Alzheimers Dis
; 53(3): 1193-207, 2016 06 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-27372638
17.
Erratum to 'Poly (ADP-ribose) polymerase inhibitors in solid tumours: Systematic review and meta-analysis' [Eur J Cancer 149 (2021) 134-152].
Eur J Cancer
; 153: 274, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34176706
Resultados
1 -
17
de 17
1
Próxima >
>>